Point72 Asset Management, L.P. - CYMABAY THERAPEUTICS INC ownership

CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 108 filers reported holding CYMABAY THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.41 and the average weighting 0.4%.

Quarter-by-quarter ownership
Point72 Asset Management, L.P. ownership history of CYMABAY THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$36,230,167
+20072.0%
2,429,924
+11697.5%
0.11%
+10500.0%
Q1 2023$179,606
-82.6%
20,597
-94.1%
0.00%
-75.0%
Q2 2022$1,033,000
-55.1%
350,000
-48.6%
0.00%
-55.6%
Q4 2021$2,303,000
+14.5%
681,401
+18.2%
0.01%
-30.8%
Q2 2020$2,012,000
-87.6%
576,638
-81.8%
0.01%
-86.9%
Q3 2019$16,182,000
-44.9%
3,160,600
-22.9%
0.10%
-35.3%
Q2 2019$29,346,000
+1597.3%
4,098,630
+1765.4%
0.15%
+1812.5%
Q4 2018$1,729,000
+110.3%
219,715
+196.1%
0.01%
+166.7%
Q3 2018$822,000
-27.8%
74,197
-91.2%
0.00%
-66.7%
Q1 2016$1,139,000
-34.9%
843,800
-18.5%
0.01%
-35.7%
Q4 2015$1,750,000
-12.8%
1,035,2880.0%0.01%
-12.5%
Q3 2015$2,008,000
+27.6%
1,035,288
+76.9%
0.02%
+45.5%
Q2 2015$1,574,000
-61.1%
585,2880.0%0.01%
-60.7%
Q1 2015$4,050,000
-27.9%
585,288
+2.5%
0.03%
-28.2%
Q4 2014$5,614,000571,0880.04%
Other shareholders
CYMABAY THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Lynx1 Capital Management LP 1,653,495$10,367,4148.97%
Versant Venture Management, LLC 543,753$3,409,3307.06%
TCG Crossover Management, LLC 5,905,400$37,026,8586.54%
COMMODORE CAPITAL LP 5,738,500$35,9805.42%
Foresite Capital Management IV, LLC 1,787,094$11,205,0794.79%
Saturn V Capital Management LP 1,611,778$5,718,4324.74%
ACUTA CAPITAL PARTNERS, LLC 1,015,000$6,364,0503.92%
Altium Capital Management LP 1,025,000$6,426,7503.27%
Affinity Asset Advisors, LLC 1,143,531$7,169,9392.81%
GREAT POINT PARTNERS LLC 1,550,000$9,718,5001.90%
View complete list of CYMABAY THERAPEUTICS INC shareholders